PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple myeloma |
| Symptom | C0032131|plasmacytomas |
| Sentences | 8 |
| PubMedID- 24986687 | Our results for plasmacytomas highlight the significance of antiapoptotic changes in multiple myeloma, which include elevated expression of mcl-1 and, less frequently, bcl-2, and suggest that closer attention to defects in bim expression is warranted. |
| PubMedID- 22738942 | No clinical, laboratory, or imaging findings indicative of multiple myeloma or association with other plasmacytomas were found, so the tumor was considered to be a primary pancreatic plasmacytoma. |
| PubMedID- 25192483 | We reviewed the pertinent literature and reached the following conclusions: sellar plasmacytomas with development of multiple myeloma on follow-up more likely happened in men than in women; and if the sellar plasmacytoma does not compress the cranial nerve, transsphenoidal resection should be cautious because the systemic treatment with radiotherapy, chemotherapy, and autologous peripheral blood stem cell transplantation may be more effective with little invasion. |
| PubMedID- 22105527 | Incidence of plasmacytomas associated with multiple myeloma range from 7% to 17% at diagnosis and from 6% to 20% during the course of the disease. |
| PubMedID- 23326271 | Recurrent plasmacytomas after allografting in a patient with multiple myeloma. |
| PubMedID- 25694834 | A final diagnosis of multiple myeloma complicated with extramedullary plasmacytomas involving the pancreas, suprarenal gland, kidney, skin, lung, liver, spleen, and lymph nodes was attained. |
| PubMedID- 21900099 | Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. |
| PubMedID- 20944171 | Background: a case of relapsed multiple myeloma (mm) with multiple plasmacytomas of the parietal bone and the right orbit in which was achieved a complete response with bortezomib plus dexamethasone (bd) therapy is reported. |
Page: 1